Abstract:Abstract Background As the novel coronavirus triggering COVID-19 has broken out in Wuhan, China and spread rapidly worldwide, it threatens the lives of thousands of people and poses a global threat on the economies of the entire world. However, infection with COVID-19 is currently rare in children. Objective To discuss the latest findings and research focus on the basis of characteristics of children confirmed with COVID-19, and provide an insight into the future treatment and research direction. Methods We searched the terms “COVID-19 OR coronavirus OR SARS-CoV-2” AND “Pediatric OR children” on PubMed, Embase, Cochrane library, NIH, CDC, and CNKI. The authors also reviewed the guidelines published on Chinese CDC and Chinese NHC. Results We included 25 published literature references related to the epidemiology, clinical manifestation, accessary examination, treatment, and prognosis of pediatric patients with COVID-19. Conclusion The numbers of children with COVID-19 pneumonia infection are small, and most of them come from family aggregation. Symptoms are mainly mild or even asymptomatic, which allow children to be a risk factor for transmission. Thus, strict epidemiological history screening is needed for early diagnosis and segregation. This holds especially for infants, who are more susceptible to infection than other age groups in pediatric age, but have most likely subtle and unspecific symptoms. They need to be paid more attention to. CT examination is a necessity for screening the suspected cases, because most of the pediatric patients are mild cases, and plain chest X-ray do not usually show the lesions or the detailed features. Therefore, early chest CT examination combined with pathogenic detection is a recommended clinical diagnosis scheme in children. The risk factors which may suggest severe or critical progress for children are: Fast respiratory rate and/or; lethargy and drowsiness mental state and/or; lactate progressively increasing and/or; imaging showed bilateral or multi lobed infiltration, pleural effusion or rapidly expending of lesions in a short period of time and/or; less than 3 months old or those who underly diseases. For those critical pediatric patients with positive SARS-CoV-2 diagnosis, polypnea may be the most common symptom. For treatment, the elevated PCT seen in children in contrast to adults suggests that the underlying coinfection/secondary infection may be more common in pediatric patients and appropriate antibacterial treatment should be considered. Once cytokine storm is found in these patients, anti-autoimmune or blood-purifying therapy should be given in time. Furthermore, effective isolation measures and appropriate psychological comfort need to be provided timely.

[Recommendations on the clinical management of the COVID-19 infection by the «new coronavirus» SARS-CoV2. Spanish Paediatric Association working group]

Diagnosis, Treatment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: Experts' Consensus Statement Updated for the Omicron Variant.

Benefits, Open Questions and Challenges of the Use of Ultrasound in the COVID-19 Pandemic Era. the Views of a Panel of Worldwide International Experts

Chinese Expert Consensus on the Perinatal and Neonatal Management for the Prevention and Control of the 2019 Novel Coronavirus Infection (first Edition)

[Diagnosis and Treatment Recommendation for Pediatric Coronavirus Disease-19].

Recommendations Regarding the Admission, Infection Prevention and Control of Pediatric Patients During Coronavirus Disease 2019 Outbreak in Shanghai China

Expert Consensus for Managing Pregnant Women and Neonates Born to Mothers with Suspected or Confirmed Novel Coronavirus (COVID‐19) Infection

Management in the paediatric wards facing novel coronavirus infection: a rapid review of guidelines and consensuses

A Mini Review on Current Clinical and Research Findings for Children Suffering from COVID-19

Non-Pharmacological Interventions During SARS-CoV-2 Pandemic: Effects on Pediatric Viral Respiratory Infections

Guidelines for the prevention and management of children and adolescents with COVID-19

Childhood COVID-19: a Multicentre Retrospective Study

Update June 2022: Management of Hospitalised Adults with Coronavirus Disease 2019 (COVID-19): a European Respiratory Society Living Guideline.

Take Precautions Beforehand: Calling for Clinical Trials of Pediatric Drugs for Treating Coronavirus Disease 2019.

Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus

Advices on the Prevention and Control of Nosocomial Infection of Novel Coronavirus Within Children’s Hospitals

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

SARS-CoV-2 infections with emphasis on pediatric patients: a narrative review

What if COVID-19 affects the child: which weapons and how to use them

Diagnosis, Treatment, and Prevention of 2019 Novel Coronavirus Infection in Children: Experts’ Consensus Statement

Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2